There is so much in here to be scared about on climate change.  I listened to this book but had to get the e-book because he was going over so many facts and statistics that I was having a hard time understanding it and keeping up.  I liked that he broke the crisis into smaller pieces.  I liked that he spoke of who would be most affected by the changes as well as how they would be affected.  We all will be affected eventually but those in poorer countries and those who are poor will be affected earlier and more than those who are wealthy.  I did find it interesting that as he was talking about wildfires, he explained that those who are wealthy, and living in those areas, are being affected as much as those who are poor.  The increase of weather changes, floods, and fires was amazing, and it all happened within the last 50 years.  He did not give solutions but shared who was doing what when it came to that.  He lays out a convincing argument for climate change and what will happen to the planet and humans and how we have contributed to it in the past and today.  Worth the read.

For all you Hitchhiker's Guide to the Galaxy fans -- win and wear the ultimate answer

Why 42?

Forty-two is the answer to life, the universe and everything, in Douglas Adams’s masterpiece, a surreal and goofy romp through the universe.

Enter now!

Why giveaway this?

Because I think that fans of HHGTTG will also enjoy my new book, Alpha Max: An Existential Romp through an Absurd Multiverse. Now, I’m not saying Alpha Max is as funny HHGTTG, because that’s a pretty high bar.

However, I have some earlier reviewers compare this work to that of Douglas Adams, Terry Pratchett and also Kurt Vonnegut. The winner will also receive a signed, first edition copy of my new book!

The global life science instrumentation market size is projected to grow from an estimated USD 60.0 billion in 2020 to USD 79.9 billion by 2025, at a CAGR of 5.9% during the forecast period.

Market growth is driven largely by factors, such as increasing expenditure on research & development by pharmaceutical & biotechnology companies, growing public & private funding for life science research, and rising incidence of target diseases & genetic disorders. The emerging markets and increasing demand for analytical instruments are expected to present avenues of growth for market players.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38

The research application segment was the largest contributor to the life science instrumentation market in 2019

The research application segment accounted for the largest share of the life science instrumentation application market in 2019. The large share of the research applications segment can be attributed to evolving global regulatory scenarios for research data publication in analytical instruments-based researches, an increasing number of research studies coupled with growing public-private funding in the field of genomic researches, and the ongoing trend of laboratory automation & integration of robotics.

Next-generation sequencing (NGS) to register the highest growth over the forecast period among life science instrumentation technologies

The Next-generation sequencing (NGS) segment is expected to register the highest growth over the forecast among the life science instrumentation technologies market over the forecast period. The significant growth of this segment is attributed to the advantages offered by NGS technologies in DNA sequencing, which substantially provides more throughput and minimizes the need for fragment-cloning methods. In addition, continuous technological advancements and the increasing availability of cheaper sequencing platforms

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=38

Asia Pacific is expected to grow at the highest CAGR in the life science instrumentation market during the forecast period

The Asia Pacific is one of the major revenue-generating regions in the life science instrumentation industry. The strategic expansions by key market players in emerging Asian countries, the growing pharmaceutical industry in India & China, and conferences, exhibitions, & meetings on analytical instruments is driving growth in the region.

Key Market Players

Agilent Technologies (US), Becton, Dickinson, and Company (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Eppendorf AG (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer, Inc. (US), Qiagen N.V. (Netherlands), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (US), and Waters Corporation (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst